INSM1 (Insulinoma-associated 1) is a transcriptional repressor protein involved in neuroendocrine cell differentiation. The INSM1 Antibody (e.g., BSB-123 from Bio SB) is a mouse monoclonal IgG1 antibody designed to detect INSM1 expression in tissues. It is widely used in immunohistochemistry (IHC) to identify neuroendocrine tumors, including small cell lung carcinoma (SCLC), medullary thyroid carcinoma, and Merkel cell carcinoma .
Neuroendocrine Tumors: INSM1 Antibody demonstrates high sensitivity and specificity for SCLC, often outperforming traditional markers like chromogranin A and synaptophysin .
Developmental Biology: INSM1 is expressed in fetal neuroendocrine tissues and developing neurons, making it a marker for neuroendocrine lineage .
Diagnostic Utility: The antibody reacts with human, mouse, and rat tissues, tested in ELISA, Western blot, and IHC .
Tumor Profiling: Studies show INSM1 is expressed in >90% of SCLC cases and is absent in most non-neuroendocrine tumors, validating its use as a diagnostic biomarker .
Therapeutic Implications: INSM1 regulates neuroendocrine differentiation in lung cancer, suggesting potential targets for therapy .
INSM1 Antibody is distinct from other neuroendocrine markers due to its:
High specificity: Avoids cross-reactivity with non-neuroendocrine tissues .
Broad applicability: Validated across species (human, mouse, rat) and techniques (ELISA, WB, IHC) .
Species-specificity: Primarily validated for human, mouse, and rat samples; other species require further testing .
Clinical Context: Requires correlation with histopathological and radiological findings for accurate diagnosis .
- Bio SB. INSM1 Antibody (BSB-123).
- Boster Bio. Anti-IA-1 INSM1 Antibody (A05005).
- PMC. Role of Inn1 and its interactions with Hof1 and Cyk3 in promoting cytokinesis.
KEGG: sce:YNL152W
STRING: 4932.YNL152W
INN1 Antibody targets the INN1 protein, which appears to be essential for the ingression of the plasma membrane into the bud neck during cellular division processes. Antibodies like this serve as critical tools for studying protein localization and function within cellular compartments. When designing experiments to study membrane dynamics using INN1 Antibody, researchers should consider fixation methods that preserve membrane integrity while maintaining epitope accessibility.
For optimal results in membrane protein studies, researchers should employ multiple complementary techniques to validate observations, such as combining immunofluorescence with biochemical fractionation approaches. Recent studies in antibody research have demonstrated that membrane protein targeting requires careful optimization of detergent conditions during sample preparation to maintain native conformations while allowing antibody access.
Antibody specificity validation is crucial for reliable research outcomes. Based on current antibody research standards, researchers should implement multiple validation approaches:
Western blot analysis comparing wild-type and knockout/knockdown samples
Immunoprecipitation followed by mass spectrometry to confirm target identity
Immunofluorescence with appropriate controls for subcellular localization
Recent advances in antibody specificity testing have employed phage display experiments to thoroughly evaluate binding profiles, as demonstrated in studies of antibody libraries against various ligand combinations . For membrane-associated proteins like INN1, researchers should particularly focus on validating antibody performance in membrane fractions, as extraction conditions can significantly affect epitope accessibility and recognition.
Proper storage and handling are essential for maintaining antibody functionality. Based on established protocols for research-grade antibodies:
| Storage Condition | Recommended Practice | Rationale |
|---|---|---|
| Long-term storage | -80°C in small aliquots | Minimizes freeze-thaw cycles |
| Working storage | 4°C for up to 2 weeks | Reduces degradation while maintaining accessibility |
| Buffer composition | PBS with 0.02% sodium azide | Prevents microbial growth |
| Protein stabilizers | Addition of 1% BSA or glycerol | Prevents adsorption to tube walls |
When handling antibodies targeting membrane proteins like INN1, researchers should avoid detergents during initial storage, as these can affect binding capacity over time. Antibody performance should be regularly validated, particularly when studying membrane-associated proteins where preparation methods can impact epitope recognition.
Effective experimental design requires careful consideration of multiple parameters. When working with INN1 Antibody for studying membrane proteins:
Sample preparation method must preserve the native conformation of membrane-embedded epitopes
Blocking agents should be selected to minimize background while maintaining specific binding
Incubation temperature and duration should be optimized for epitope accessibility
For membrane protein studies, researchers might need to evaluate different detergent types and concentrations during sample preparation. Research on antibody binding interactions demonstrates the importance of optimizing multiple experimental parameters simultaneously rather than individually . When designing experiments targeting membrane proteins, researchers should validate findings using complementary approaches that don't rely solely on antibody binding.
Non-specific binding represents a common challenge in antibody-based experiments. Systematic troubleshooting approaches include:
Titration of antibody concentration to find optimal signal-to-noise ratio
Evaluation of different blocking reagents (BSA, milk, commercial blockers)
Increased washing stringency with detergent concentrations adjusted for membrane proteins
Pre-adsorption of antibody with related antigens to remove cross-reactive antibodies
When studying membrane proteins like INN1, researchers should be particularly attentive to detergent conditions that may expose non-specific epitopes. Recent advances in antibody engineering have shown that modifications to antibody structure can significantly affect binding specificity and tissue distribution profiles . For membrane protein studies, gradient centrifugation to isolate specific membrane fractions before immunodetection can significantly reduce background.
Robust controls are fundamental to reliable antibody-based research:
| Control Type | Purpose | Implementation |
|---|---|---|
| Positive control | Confirms antibody functionality | Known positive sample or recombinant protein |
| Negative control | Identifies non-specific signals | Knockout/knockdown samples or pre-immune serum |
| Isotype control | Evaluates background binding | Matched isotype antibody with irrelevant specificity |
| Secondary antibody only | Detects non-specific secondary binding | Omission of primary antibody |
| Blocking peptide | Validates binding specificity | Pre-incubation with immunizing peptide |
For membrane proteins like INN1, additional controls should include samples processed with different membrane solubilization methods to account for extraction-dependent epitope exposure. Modifications to antibody structure, particularly in the Fc region, can significantly affect binding characteristics and tissue distribution, as demonstrated by comparative biodistribution studies .
Computational methods have revolutionized antibody engineering for enhanced specificity:
In silico design of antibody libraries can generate thousands of variant sequences with customized binding profiles
Machine learning algorithms can predict antibody-antigen binding based on sequence and structural features
Molecular dynamics simulations can optimize complementarity-determining regions (CDRs)
Recent research has demonstrated the power of computational approaches in designing antibody libraries, with studies generating 29,900 sequence variants for each antibody chain from just a few seed sequences . For membrane protein targets like INN1, computational methods can be particularly valuable in designing antibodies that recognize specific conformational epitopes while avoiding hydrophobic regions that might lead to non-specific interactions.
Investigating protein-protein interactions involving membrane proteins requires specialized approaches:
Proximity ligation assays (PLA) to detect interactions in situ with minimal disruption
Crosslinking followed by immunoprecipitation and mass spectrometry (XL-IP-MS)
Fluorescence resonance energy transfer (FRET) for quantifying interaction dynamics in living cells
Split-GFP complementation assays to visualize interaction events
When studying membrane protein interactions, researchers should carefully evaluate detergent conditions that maintain native interactions while allowing antibody access. Studies in antibody engineering have shown that modifications to antibody structure can significantly impact tissue distribution and clearance properties, which should be considered when designing in vivo interaction studies .
Quantitative analysis of antibody binding characteristics provides crucial insights for research applications:
Surface plasmon resonance (SPR) for real-time binding kinetics measurement
Bio-layer interferometry (BLI) for label-free quantification of association/dissociation rates
Isothermal titration calorimetry (ITC) for thermodynamic binding parameters
AlphaSeq assays for high-throughput quantitative binding score determination
Recent advances in antibody research have developed systems to collect quantitative binding scores for tens of thousands of antibodies simultaneously, enabling comprehensive characterization of binding profiles . For membrane proteins like INN1, researchers should consider specialized approaches such as nanodiscs or supported lipid bilayers to maintain native membrane environments during binding studies.
Contradictory results require systematic investigation and analytical approaches:
Evaluate antibody batch variation by comparing lot numbers and validation documentation
Assess experimental conditions that might affect epitope accessibility, particularly for membrane proteins
Consider cell type-specific differences in post-translational modifications
Implement orthogonal methods that don't rely on antibody binding
Studies in antibody research have demonstrated that even single amino acid changes in antibody sequences can dramatically alter binding profiles and tissue distribution . For membrane proteins like INN1, contradictory results often stem from differences in membrane preparation methods that affect protein conformation and epitope accessibility. Researchers should systematically document and compare all experimental variables between contradictory experiments.
Statistical analysis of antibody binding data requires methods that account for biological variability:
Mixed-effects models to account for batch-to-batch antibody variation
Non-parametric tests when distribution assumptions cannot be verified
Multiple comparison corrections for high-throughput binding analyses
Bayesian approaches for integrating prior knowledge with experimental data
Recent advances in antibody research have employed sophisticated statistical frameworks to analyze binding interactions for thousands of antibodies simultaneously, allowing researchers to identify subtle patterns in binding profiles . For membrane protein studies, researchers should incorporate statistical approaches that account for the additional variability introduced by membrane preparation methods.
Differentiating specific from non-specific binding represents a critical challenge:
Competitive binding assays with unlabeled antibody or antigen
Absorption controls using recombinant antigen
Comparison of staining patterns with multiple antibodies targeting different epitopes
Correlation of antibody binding with independent measures of target expression
Research on antibody binding has demonstrated that modifications to the Fc region can dramatically affect tissue distribution patterns, highlighting the importance of antibody structure in determining binding specificity . For membrane proteins like INN1, researchers should employ tissue fractionation approaches to compare binding patterns in different subcellular compartments as an additional specificity control.
Cutting-edge antibody engineering techniques are expanding research possibilities:
Recombinant antibody fragments (Fab, scFv) for improved tissue penetration
Site-specific conjugation strategies for precise labeling
Bispecific antibodies for studying protein-protein interactions
Nanobodies derived from camelid antibodies for accessing restricted epitopes
Recent advances in antibody engineering have demonstrated the impact of structural modifications on biodistribution and clearance properties, with studies showing how even small changes in antibody sequences can dramatically alter in vivo behavior . For membrane proteins like INN1, engineered antibody formats with reduced size can provide significant advantages in accessing epitopes in densely packed membrane environments.
Innovative imaging approaches are revolutionizing antibody-based visualization:
Super-resolution microscopy techniques (STORM, PALM) for nanoscale localization
Expansion microscopy for physical specimen enlargement
Correlative light and electron microscopy (CLEM) for contextualizing molecular data
Live-cell imaging with minimally disruptive antibody fragments
For membrane proteins like INN1, advanced imaging approaches can reveal dynamic behaviors and interactions within their native membrane environment. When designing imaging experiments, researchers should consider how antibody properties like size and binding kinetics might affect the biological processes being studied, particularly for live imaging applications.
Computational prediction of antigenic determinants enhances antibody development:
Machine learning algorithms trained on antibody-antigen crystal structures
Molecular dynamics simulations of protein surface accessibility
Evolutionary analysis to identify conserved and variable regions
Structural prediction of conformational epitopes in membrane proteins
Recent research has demonstrated the power of computational approaches in antibody engineering, with studies using in silico design to generate antibody libraries with specific binding profiles . For membrane proteins like INN1, specialized algorithms that incorporate membrane topology predictions can significantly improve epitope prediction accuracy by accounting for regions embedded within the lipid bilayer.